1
|
Rodust PM, Stockfleth E, Ulrich C,
Leverkus M and Eberle J: UV-induced squamous cell carcinoma-a role
for antiapoptotic signalling pathways. Br J Dermatol. 161 (Suppl
3):S107–S115. 2009. View Article : Google Scholar
|
2
|
Molho-Pessach V and Lotem M: Ultraviolet
radiation and cutaneous carcinogenesis. Curr Probl Dermatol.
35:14–27. 2007. View Article : Google Scholar : PubMed/NCBI
|
3
|
de Villiers EM, Ruhland A and Sekarić P:
Human papillomaviruses in non-melanoma skin cancer. Semin Cancer
Biol. 9:413–422. 1999. View Article : Google Scholar : PubMed/NCBI
|
4
|
McNaughton SA, Marks GC and Green AC: Role
of dietary factors in the development of basal cell cancer and
squamous cell cancer of the skin. Cancer Epidemiol Biomarkers Prev.
14:1596–1607. 2005. View Article : Google Scholar : PubMed/NCBI
|
5
|
Ramsay HM, Fryer AA, Reece S, Smith AG and
Harden PN: Clinical risk factors associated with nonmelanoma skin
cancer in renal transplant recipients. Am J Kidney Dis. 36:167–176.
2000. View Article : Google Scholar : PubMed/NCBI
|
6
|
Giglia-Mari G and Sarasin A: TP53
mutations in human skin cancers. Hum Mutat. 21:217–228. 2003.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Madan V, Lear JT and Szeimies RM:
Non-melanoma skin cancer. Lancet. 375:673–685. 2010. View Article : Google Scholar : PubMed/NCBI
|
8
|
Eisemann N, Jansen L, Castro FA, Chen T,
Eberle A, Nennecke A, Zeissig SR, Brenner H and Katalinic A; GEKID
Cancer Survival Working Group, : Survival with nonmelanoma skin
cancer in Germany. Br J Dermatol. 174:778–785. 2016. View Article : Google Scholar : PubMed/NCBI
|
9
|
Stieglitz B, Haire LF, Dikic I and
Rittinger K: Structural analysis of SHARPIN, a subunit of a large
multi-protein E3 ubiquitin ligase, reveals a novel dimerization
function for the pleckstrin homology superfold. J Biol Chem.
287:20823–20829. 2012. View Article : Google Scholar : PubMed/NCBI
|
10
|
Seymour RE, Hasham MG, Cox GA, Shultz LD,
Hogenesch H, Roopenian DC and Sundberg JP: Spontaneous mutations in
the mouse Sharpin gene result in multiorgan inflammation, immune
system dysregulation and dermatitis. Genes Immun. 8:416–421. 2007.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Ikeda F, Deribe YL, Skånland SS, Stieglitz
B, Grabbe C, Franz-Wachtel M, van Wijk SJ, Goswami P, Nagy V,
Terzic J, et al: SHARPIN forms a linear ubiquitin ligase complex
regulating NF-κB activity and apoptosis. Nature. 471:637–641. 2011.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Tokunaga F, Nakagawa T, Nakahara M, Saeki
Y, Taniguchi M, Sakata S, Tanaka K, Nakano H and Iwai K: SHARPIN is
a component of the NF-κB-activating linear ubiquitin chain assembly
complex. Nature. 471:633–636. 2011. View Article : Google Scholar : PubMed/NCBI
|
13
|
Haas AL: Linear polyubiquitylation: The
missing link in NF-kappaB signalling. Nat Cell Biol. 11:116–118.
2009. View Article : Google Scholar : PubMed/NCBI
|
14
|
Tokunaga F, Sakata S, Saeki Y, Satomi Y,
Kirisako T, Kamei K, Nakagawa T, Kato M, Murata S, Yamaoka S, et
al: Involvement of linear polyubiquitylation of NEMO in NF-kappaB
activation. Nat Cell Biol. 11:123–132. 2009. View Article : Google Scholar : PubMed/NCBI
|
15
|
Wang Z, Potter CS, Sundberg JP and
Hogenesch H: SHARPIN is a key regulator of immune and inflammatory
responses. J Cell Mol Med. 16:2271–2279. 2012. View Article : Google Scholar : PubMed/NCBI
|
16
|
Rantala JK, Pouwels J, Pellinen T, Veltel
S, Laasola P, Mattila E, Potter CS, Duffy T, Sundberg JP,
Kallioniemi O, et al: SHARPIN is an endogenous inhibitor of
β1-integrin activation. Nat Cell Biol. 13:1315–1324. 2011.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Jung J, Kim JM, Park B, Cheon Y, Lee B,
Choo SH, Koh SS and Lee S: Newly identified tumor-associated role
of human Sharpin. Mol Cell Biochem. 340:161–167. 2010. View Article : Google Scholar : PubMed/NCBI
|
18
|
Sieber S, Lange N, Kollmorgen G, Erhardt
A, Quaas A, Gontarewicz A, Sass G, Tiegs G and Kreienkamp HJ:
Sharpin contributes to TNFα dependent NFκB activation and
anti-apoptotic signalling in hepatocytes. PLoS One. 7:e299932012.
View Article : Google Scholar : PubMed/NCBI
|
19
|
De Melo J and Tang D: Elevation of SIPL1
(SHARPIN) increases breast cancer risk. PLoS One. 10:e01275462015.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Zhang Y, Huang H, Zhou H, Du T, Zeng L,
Cao Y, Chen J, Lai Y, Li J, Wang G, et al: Activation of nuclear
factor κB pathway and downstream targets survivin and livin by
SHARPIN contributes to the progression and metastasis of prostate
cancer. Cancer. 120:3208–3218. 2014. View Article : Google Scholar : PubMed/NCBI
|
21
|
Li Q, Li M, Ma L, Li W, Wu X, Richards J,
Fu G, Xu W, Bythwood T, Li X, et al: A method to evaluate
genome-wide methylation in archival formalin-fixed,
paraffin-embedded ovarian epithelial cells. PLoS One.
9:e1044812014. View Article : Google Scholar : PubMed/NCBI
|
22
|
Bii VM, Rae DT and Trobridge GD: A novel
gammaretroviral shuttle vector insertional mutagenesis screen
identifies SHARPIN as a breast cancer metastasis gene and
prognostic biomarker. Oncotarget. 6:39507–39520. 2015. View Article : Google Scholar : PubMed/NCBI
|
23
|
Haris K, Ismail S, Idris Z, Abdullah JM
and Yusoff AA: Expression profile of genes modulated by Aloe emodin
in human U87 glioblastoma cells. Asian Pac J Cancer Prev.
15:4499–4505. 2014. View Article : Google Scholar : PubMed/NCBI
|
24
|
Ghaheri M, Kahrizi D, Yari K, Babaie A,
Suthar RS and Kazemi E: A comparative evaluation of four DNA
extraction protocols from whole blood sample. Cell Mol Biol.
62:120–124. 2016.PubMed/NCBI
|
25
|
Bollag G, Hirth P, Tsai J, Zhang J,
Ibrahim PN, Cho H, Spevak W, Zhang C, Zhang Y, Habets G, et al:
Clinical efficacy of a RAF inhibitor needs broad target blockade in
BRAF-mutant melanoma. Nature. 467:596–599. 2010. View Article : Google Scholar : PubMed/NCBI
|
26
|
Kallini JR, Hamed N and Khachemoune A:
Squamous cell carcinoma of the skin: Epidemiology, classification,
management, and novel trends. Int J Dermatol. 54:130–140. 2015.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Paolino G, Donati M, Didona D, Mercuri SR
and Cantisani C: Histology of non-melanoma skin cancers: An update.
Biomedicines. 5(pii): E712017. View Article : Google Scholar : PubMed/NCBI
|
28
|
De Melo J, Lin X, He L, Wei F, Major P and
Tang D: SIPL1-facilitated PTEN ubiquitination contributes to its
association with PTEN. Cell Signal. 26:2749–2756. 2014. View Article : Google Scholar : PubMed/NCBI
|
29
|
Weedon DD, Malo J, Brooks D and Williamson
R: Squamous cell carcinoma arising in keratoacanthoma: A neglected
phenomenon in the elderly. Am J Dermatopathol. 32:423–426. 2010.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Vasiljević N, Andersson K, Bjelkenkrantz
K, Kjellström C, Månsson H, Nilsson E, Landberg G, Dillner J and
Forslund O: The Bcl-xL inhibitor of apoptosis is preferentially
expressed in cutaneous squamous cell carcinoma compared with that
in keratoacanthoma. Int J Cancer. 124:2361–2366. 2009. View Article : Google Scholar : PubMed/NCBI
|
31
|
Karin M and Greten FR: NF-kappaB: Linking
inflammation and immunity to cancer development and progression.
Nat Rev Immunol. 5:749–759. 2005. View
Article : Google Scholar : PubMed/NCBI
|
32
|
van Hogerlinden M, Rozell BL,
Ahrlund-Richter L and Toftgård R: Squamous cell carcinomas and
increased apoptosis in skin with inhibited Rel/nuclear
factor-kappaB signaling. Cancer Res. 59:3299–3303. 1999.PubMed/NCBI
|
33
|
Michalak EM, Vandenberg CJ, Delbridge AR,
Wu L, Scott CL, Adams JM and Strasser A: Apoptosis-promoted
tumorigenesis: Gamma-irradiation-induced thymic lymphomagenesis
requires Puma-driven leukocyte death. Genes Dev. 24:1608–1613.
2010. View Article : Google Scholar : PubMed/NCBI
|
34
|
Li F, Huang Q, Chen J, Peng Y, Roop DR,
Bedford JS and Li CY: Apoptotic cells activate the ‘phoenix rising’
pathway to promote wound healing and tissue regeneration. Sci
Signal. 3:ra132010. View Article : Google Scholar : PubMed/NCBI
|
35
|
Huang Q, Li F, Liu X, Li W, Shi W, Liu FF,
O'Sullivan B, He Z, Peng Y, Tan AC, et al: Caspase 3-mediated
stimulation of tumor cell repopulation during cancer radiotherapy.
Nat Med. 17:860–866. 2011. View
Article : Google Scholar : PubMed/NCBI
|
36
|
Qiu W, Wang X, Leibowitz B, Yang W, Zhang
L and Yu J: PUMA-mediated apoptosis drives chemical
hepatocarcinogenesis in mice. Hepatology. 54:1249–1258. 2011.
View Article : Google Scholar : PubMed/NCBI
|
37
|
Ichim G and Tait SW: A fate worse than
death: Apoptosis as an oncogenic process. Nat Rev Cancer.
16:539–548. 2016. View Article : Google Scholar : PubMed/NCBI
|
38
|
Scott GA, Laughlin TS and Rothberg PG:
Mutations of the TERT promoter are common in basal cell carcinoma
and squamous cell carcinoma. Mod Pathol. 27:516–523. 2014.
View Article : Google Scholar : PubMed/NCBI
|